e-learning
resources
Stockholm 2007
Sunday 16.09.2007
New treatments for asthma and COPD - experimental evidence
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In-depth characterization of
in vivo
LPS models
E. Benediktus, R. Goeggel, B. Jung (Biberach, Germany)
Source:
Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Session:
New treatments for asthma and COPD - experimental evidence
Session type:
Electronic Poster Discussion
Number:
313
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Benediktus, R. Goeggel, B. Jung (Biberach, Germany). In-depth characterization of
in vivo
LPS models. Eur Respir J 2007; 30: Suppl. 51, 313
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Modeling in vitro, ex vivo or in vivo?
Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development
Year: 2013
A human-like ex vivo preclinical model for aerosol deposition studies
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
In vitro and in vivo studies of nanoparticles and the lung
Source: International Congress 2014 – Nanomaterials and respiratory health
Year: 2014
Detailed physiological profiling of patients for a study investigating the airway microbiome
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018
A comparative study of pulmonary host defense in murine obesity models: Important insights into neutrophil function
Source: International Congress 2016 – Translational research in respiratory infections
Year: 2016
Breathprinting of multiple bacterial lung pathogens in vitro and in mice: what we can learn from translational approaches
Source: International Congress 2014 – Usefulness of exhaled volatile organic compounds (VOCs) for the monitoring and understanding of lung diseases
Year: 2014
Imaging of animal models: in vivo we can learn more
Source: Annual Congress 2008 - Computer-aided imaging of lung parenchyma and airways
Year: 2008
In vivo and in vitro regulation of angiopoietin expression by bacterial lipopolysaccharides (LPS)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008
Hemodynamic and respiratory assessement of an ex vivo perfused rat lung model
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
In vitro
and
in vivo
laboratory models of pleural disease
Source: Eur Respir Monogr 2020; 87: 29-47
Year: 2020
Quantitative proteomic analysis: methods and applications
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004
In vitro and in vivo characterisation of the novel neutrophil elastase inhibitor BI 1323495
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020
Proteomic profiling to define synergistic responses mediated by IL-17 and TNFa in the lungs
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Pulmonary mechanics in a mouse model of emphysema: in vivo and in vitro evaluation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
In silico model of the spectrum of reactivity to mycobacteria
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010
Use of biomaterials to tissue engineer 3D models with lung organoids for in-vitro disease modelling
Source: Virtual Congress 2020 – Lung epithelial development and repair in three-dimensions
Year: 2020
An integrated culture system for in vitro human airway modeling
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004
Effects of anti-IL-5 receptor alpha in an ex vivo 3D model of COPD
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept